Mesenteric Ischemia

Mesenteric ischemia is a vascular emergency caused by inadequate blood flow to the intestines, carrying a mortality rate of 50–80% when acute. [1-2] It encompasses four subtypes: arterial embolism (40–50%), arterial thrombosis (15–35%), nonocclusive mesenteric ischemia (NOMI) (5–15%), and mesenteric venous thrombosis (MVT) (5–15%). [1][3] The key to survival is a high index of clinical suspicion and early diagnosis. [2]

• Cardinal symptom: Severe, acute-onset abdominal pain — classically "pain out of proportion to physical examination" [2-3]
• Timing by subtype:
  • Embolic: Sudden, severe onset; often periumbilical [4]
  • Thrombotic: Acute worsening of chronic postprandial pain and weight loss ("acute-on-chronic") [2]
  • NOMI: Diffuse, episodic pain in the setting of critical illness or low-flow state [2]
  • MVT: More insidious onset with cramping, nausea, vomiting, diarrhea [2-3]
• Ask about atrial fibrillation, recent MI, heart failure, prior embolic events, recent cardiac or abdominal surgery, hypercoagulable history [3-4]
• Chronic mesenteric ischemia (CMI): Postprandial pain, food fear (sitophobia), and unintentional weight loss [5]
• 95% present with abdominal pain; 44% nausea; 35% vomiting; 35% diarrhea; 16% blood per rectum [1-2]
• Important negatives: Absence of prior cardiovascular disease or risk factors does not exclude the diagnosis, especially in younger patients with MVT [2][6]

• Pain out of proportion to exam — assume AMI until disproven (WSES Grade 1C recommendation) [2]
• Peritoneal signs → likely irreversible bowel necrosis [2][7]
• Triad of abdominal pain + fever + heme-positive stool [7]
• Hemodynamic instability, septic shock, altered mental status
• Rapidly rising lactate, worsening metabolic acidosis
• Bloody diarrhea or frank GI hemorrhage
• Pneumatosis intestinalis or portal venous gas on imaging → late, ominous findings [2]

• Contributors/Causes:
  • Vasopressors (especially high-dose norepinephrine) → NOMI risk [2]
  • Digoxin → mesenteric vasoconstriction
  • Oral contraceptives → MVT risk [2]
  • Cocaine, ergotamines → mesenteric vasospasm
• Acute treatment:
  • IV unfractionated heparin (UFH) — initiate immediately upon diagnosis [2][8]
  • Broad-spectrum antibiotics for bacterial translocation [9]
  • Papaverine (catheter-directed) for NOMI [8]
• Post-intervention:
  • Antiplatelet therapy (aspirin ± clopidogrel × 6 months) after stent placement [2]
  • Long-term anticoagulation (warfarin or DOACs) for most patients, especially MVT and embolic causes [2][8]
• Contraindicated: Vasoconstrictors should be minimized/avoided when possible in suspected mesenteric ischemia

• Acute: NPO / bowel rest during active ischemia [2][10]
• Enteral nutrition should be withheld during ongoing ischemia-reperfusion injury; start at low rate only after revascularization is convincingly achieved [11]
• Parenteral nutrition may be required in patients with short bowel syndrome post-resection [2]
• Chronic mesenteric ischemia: Small, frequent, low-fat meals to reduce postprandial demand; nutritional supplementation for malnutrition from food avoidance [5][12]

• GI: Postprandial pain, nausea, vomiting, diarrhea, bloody stool, weight loss, food aversion
• Cardiovascular: Palpitations (atrial fibrillation), chest pain, claudication, prior stroke/TIA, prior embolic events
• Vascular: History of DVT/PE, peripheral arterial disease
• Constitutional: Fever, malaise, recent weight loss
• Hematologic: Easy bruising, prior thrombotic events, family history of clotting disorders

• Confirm cardiac history (atrial fibrillation, recent MI, valvular disease, CHF) from records or family [3-4]
• Prior embolic events (stroke, limb ischemia) — ~1/3 of embolic AMI patients have prior arterial embolus [2]
• Family history of thrombophilia (Factor V Leiden, prothrombin gene mutation, protein C/S deficiency, antithrombin deficiency) [2]
• Social history: Smoking (atherosclerotic risk), cocaine use, oral contraceptive use
• Recent hospitalizations, surgeries (especially abdominal/bariatric/splenectomy → MVT risk) [2]

• Age >70 with exponential increase >75 [1]
• COVID-19 (hypercoagulability and hypoperfusion) [2]
• End-stage renal disease / hemodialysis [9]

• Acute pancreatitis — lipase elevation, different CT findings
• Perforated viscus — free air on imaging
• Small bowel obstruction — transition point on CT, different vascular findings
• Acute cholecystitis / cholangitis — RUQ pain, Murphy's sign, biliary dilation
• Ruptured AAA — pulsatile mass, hypotension, retroperitoneal hemorrhage
• Aortic dissection — tearing pain, differential blood pressures
• Inflammatory bowel disease — chronic history, mucosal pattern on CT
• Infectious enterocolitis — fever, exposure history, different CT pattern [13]
• Ischemic colitis (distinct from AMI) — typically left-sided, self-limited, elderly with hypotension
• Angioedema of bowel wall — medication history (ACE inhibitors), wall thickening without vascular occlusion [13]

• Prior episodes of postprandial pain / "intestinal angina" → suggests chronic mesenteric ischemia at risk for acute-on-chronic event [2]
• Previous mesenteric revascularization (stent or bypass) — restenosis accounts for 6–8% of late deaths [2]
• Cardiovascular disease: CAD, CHF, atrial fibrillation, valvular disease
• Hypercoagulable states, prior DVT/PE
• Malignancy (especially abdominal)
• Cirrhosis / portal hypertension
• Prior abdominal surgery (adhesions, altered anatomy)

• Early: Abdomen may be soft and nontender despite severe pain — the hallmark "pain out of proportion to exam" [2-3]
• Late: Peritoneal signs (guarding, rigidity, rebound) → bowel necrosis [2]
• Vital signs: Tachycardia, hypotension, fever (late)
• Epigastric bruit (suggests chronic mesenteric arterial stenosis) [3]
• Assess for atrial fibrillation (irregular pulse)
• Signs of peripheral vascular disease (diminished pulses, bruits)
• Rectal exam: Heme-positive stool in ~25% [4]
• Abdominal distension (late finding)
• Mental status changes, especially in elderly [3]

• No laboratory test can definitively confirm or exclude AMI [2]
• Lactate — elevated in advanced ischemia; lactate >2 mmol/L is an independent predictor of transmural necrosis; however, a normal lactate does not rule out early disease [9-10]
• WBC — leukocytosis in >90% of patients [2]
• D-dimer — elevated; may assist but nonspecific [2]
• Metabolic panel — metabolic acidosis (elevated anion gap), hyperkalemia
• Amylase — elevated in ~50% [4]
• LDH, CK — may be elevated with bowel necrosis
• Stool guaiac — occult blood in ~25% [4]
• Coagulation studies — PT/INR, aPTT (baseline before anticoagulation)
• Type and screen — anticipate potential surgical intervention
• Hypercoagulable workup (for MVT): Protein C/S, antithrombin III, Factor V Leiden, prothrombin gene mutation, antiphospholipid antibodies [8]

• First-line / Gold standard: CT angiography (CTA) — triphasic (non-contrast + arterial + venous phase) [1][8-9]
  • Sensitivity 92%, specificity 98.8% for AMI [14]
  • Should be performed even in the setting of AKI — consequences of missed diagnosis far outweigh contrast risk [2]
  • Do NOT use oral contrast — it is harmful and delays diagnosis [2]
• Key CTA findings:
  • Vascular: SMA/SMV thrombus or embolus, arterial occlusion, dissection
  • Bowel: Decreased/absent wall enhancement, wall thickening, bowel dilation >25 mm (suggests necrosis) [15]
  • Ominous: Pneumatosis intestinalis, portal venous gas, free perforation [2]
  • MVT: "Target sign" in SMV on venous phase [2]
  • NOMI: Bowel ischemia with patent mesenteric vessels [2]
• Plain radiograph: Limited utility; only positive with late findings (pneumoperitoneum, pneumatosis) — a negative X-ray does not exclude AMI [2]
• Duplex ultrasound: Not appropriate for acute AMI (ACC/AHA Class III recommendation); useful for screening chronic disease [4-5]
• MRI: Overestimates stenosis, too slow for acute setting [1]
• Catheter angiography: Reserved for therapeutic intervention or when CTA is inconclusive [1]

• Point-of-care ultrasound (POCUS): May identify free fluid/ascites but cannot reliably diagnose AMI [6]
• Mesenteric duplex ultrasound: Preferred screening for chronic mesenteric ischemia; PSV >275 cm/s in SMA correlates with ≥70% stenosis (sensitivity 92%, specificity 96%) [8]
• Diagnostic laparoscopy: Limited role — early ischemia starts from mucosa and bowel may appear normal externally; can lead to false-negative results [16]
• Second-look laparotomy: Mandatory 24–48 hours after initial surgery in patients with extensive bowel involvement to reassess viability [2]

• Obtain ECG on all patients with suspected AMI to evaluate for:
  • Atrial fibrillation — present in ~50% of embolic AMI [2]
  • Recent or acute MI — source of cardiac embolus [4]
  • Arrhythmias contributing to low-flow states
  • Signs of right heart strain (if massive fluid shifts/sepsis)
• New atrial fibrillation + acute abdominal pain = high suspicion for embolic AMI

• AMI is an abdominal vascular emergency with in-hospital mortality of ~49% and 90-day mortality of ~53% [17]
• Mortality by subtype: NOMI has the worst prognosis (72–75% mortality), followed by arterial occlusive AMI; venous AMI has the lowest mortality (~14–16%) [17-18]
• The "classic" presentation (pain out of proportion) is becoming less common; "acute-on-chronic" presentations are more typical and likely underdiagnosed [2]
• Median time from symptom onset to hospital admission is 24 hours; time from admission to diagnosis is 6 hours — both represent opportunities for improvement [17]
• Transmural necrosis predictors: Organ failure, lactate >2 mmol/L, bowel dilation >2.5 cm on CT [10]
• Complications: Bowel necrosis, perforation, peritonitis, sepsis, multiorgan failure, short bowel syndrome, death

Initial stabilization (ED)

• Aggressive IV fluid resuscitation
• IV unfractionated heparin — initiate immediately to prevent clot propagation [2][8]
• Broad-spectrum antibiotics (cover gram-negatives and anaerobes) for bacterial translocation [9]
• Nasogastric decompression, NPO [2]
• Correct metabolic acidosis, electrolyte derangements
• Adequate analgesia (do not withhold opioids)

Definitive management by subtype

• Arterial embolism: Open or endovascular embolectomy [8]
• Arterial thrombosis: Open bypass (antegrade or retrograde) or endovascular thrombectomy/stenting; single-vessel SMA revascularization usually sufficient acutely [2][19]
• MVT: First-line is anticoagulation with UFH; surgery reserved for peritonitis or clinical deterioration; resect only obviously necrotic bowel using damage control techniques [2]
• NOMI: Treat underlying cause (optimize cardiac output, reduce vasopressors); catheter-directed papaverine infusion; anticoagulation [3][8]

Surgical principles

• Resect non-viable bowel, preserve maximum viable bowel length
• Damage control laparotomy with planned second-look at 24–48 hours [2]
• Revascularization before resection when possible — revascularization is associated with significantly lower 30-day mortality (42% vs 62%) [2]

Post-intervention

• Lifelong anticoagulation/antiplatelet therapy for most patients [2]
• Surveillance imaging for stent/graft restenosis [2]
• Nutritional rehabilitation; parenteral nutrition if short bowel syndrome develops [2]

• All confirmed AMI patients require admission — typically to the ICU [2]
• Emergent surgical or interventional radiology consultation for all confirmed cases [9]
• Peritonitis → emergent laparotomy [2]
• Hemodynamically stable, no peritoneal signs, arterial occlusion → endovascular revascularization if expertise available [16]
• MVT without peritonitis → may be managed with anticoagulation and close monitoring on a surgical service [2]
• Palliative care discussion should be considered in cases of extensive bowel necrosis in elderly/frail patients — shared decision-making is essential [2]
• Best outcomes are achieved at dedicated centers with 24-hour access to endovascular and surgical capabilities ("intestinal stroke centers") [2][20]

• Post-discharge surveillance: Mesenteric duplex ultrasound or CTA at regular intervals to monitor for restenosis (6–8% of late deaths are from AMI after revascularization) [2]
• Long-term anticoagulation compliance is critical; most patients require lifelong therapy [2]
• Cardiovascular risk factor optimization: Statins, antihypertensives, smoking cessation, antiplatelet therapy [3]
• Return precautions: Recurrent abdominal pain (especially postprandial), nausea/vomiting, bloody stool, weight loss, food avoidance
• Nutritional follow-up for patients with bowel resection — monitor for short bowel syndrome, malabsorption, vitamin deficiencies
• Hypercoagulable workup completion and hematology follow-up for MVT patients [2][8]
• Expected recovery: Variable; depends on extent of bowel resection and comorbidities. Patients with chronic mesenteric ischemia treated with endovascular stenting have higher rates of symptom recurrence (29% vs 13% for open bypass) with faster onset [21]

Images

1. Gastrointestinal Surgical Emergencies Textbook. — Ashley E. Aaron, Andrea Amabile, Ciro Andolfi, et al American College of Surgeons (2021). 2021.

2. Acute Mesenteric Ischemia: Updated Guidelines of the World Society of Emergency Surgery. — Bala M, Catena F, Kashuk J, et al. World Journal of Emergency Surgery : WJES. 2022.

3. Mesenteric Ischemia. — Clair DG, Beach JM. The New England Journal of Medicine. 2016.

4. ACC/­AHA 2005 Guidelines for the Management of Patients With Peripheral Arterial Disease (Lower Extremity, Renal, Mesenteric, and Abdominal Aortic): Executive Summary a Collaborative Report From the American Association for Vascular Surgery/­Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/­AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease) Endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; And Vascular Disease Foundation. — Hirsch AT, Haskal ZJ, Hertzer NR, et al. Journal of the American College of Cardiology. 2006.

5. Chronic Mesenteric Ischemia: Clinical Practice Guidelines From the Society for Vascular Surgery. — Huber TS, Björck M, Chandra A, et al. Journal of Vascular Surgery. 2021.

6. Acute Mesenteric Ischemia in a Child: A Rare Case Report and Diagnostic Challenge in the Emergency Department. — Ashwin Kumar VA, Barik S, Hansda U, Prusty AV, Sahoo S. The American Journal of Emergency Medicine. 2026.

7. Acute Mesenteric Ischemia: Guidelines of the World Society of Emergency Surgery. — Bala M, Kashuk J, Moore EE, et al. World Journal of Emergency Surgery : WJES. 2017.

8. The Evaluation and Management of Intestinal Ischemia. — Theodore S, Xia T, Saillant N. NEJM Evidence. 2024.

9. High Risk and Low Prevalence Diseases: Mesenteric Ischemia. — Molyneux K, Beck-Esmay J, Koyfman A, Long B. The American Journal of Emergency Medicine. 2023.

10. Portal Vein Thrombosis: Diagnosis, Management, and Endpoints for Future Clinical Studies. — Elkrief L, Hernandez-Gea V, Senzolo M, et al. The Lancet. Gastroenterology & Hepatology. 2024.

11. A Clinical Approach to Acute Mesenteric Ischemia. — Reintam Blaser A, Acosta S, Arabi YM. Current Opinion in Critical Care. 2021.

12. Imaging and Endovascular Interventions in Mesenteric Ischaemia. — Agarwal D, Gupta S, Gadwal SK, et al. Abdominal Radiology. 2025.

13. Pearls, Pitfalls, and Conditions That Mimic Mesenteric Ischemia at CT. — Fitzpatrick LA, Rivers-Bowerman MD, Thipphavong S, et al. Radiographics : A Review Publication of the Radiological Society of North America, Inc. 2020.

14. Radiological Diagnosis of Acute Mesenteric Ischemia in Adult Patients: A Systematic Review and Meta-Analysis. — Reintam Blaser A, Koitmäe M, Laisaar KT, et al. Scientific Reports. 2025.

15. Insights Into Acute Mesenteric Ischaemia: An Up-to-Date, Evidence-Based Review From a Mesenteric Stroke Centre Unit. — Garzelli L, Ben Abdallah I, Nuzzo A, et al. The British Journal of Radiology. 2023.

16. Cesena Guidelines: WSES Consensus Statement on Laparoscopic-First Approach to General Surgery Emergencies and Abdominal Trauma. — Sermonesi G, Tian BWCA, Vallicelli C, et al. World Journal of Emergency Surgery : WJES. 2023.

17. Incidence, Diagnosis, Management and Outcome of Acute Mesenteric Ischaemia: A Prospective, Multicentre Observational Study (AMESI Study). — Reintam Blaser A, Mändul M, Björck M, et al. Critical Care. 2024.

18. Acute Mesenteric Ischemia: Pathophysiology-Based Approach to Imaging Findings and Diagnosis. — Lee MH, Pickhardt PJ, Sorensen AM, et al. Radiographics : A Review Publication of the Radiological Society of North America, Inc. 2025.

19. ACR Appropriateness Criteria® Radiologic Management of Mesenteric Ischemia: 2022 Update. — Expert Panel on Interventional Radiology, Lam A, Kim YJ, et al. Journal of the American College of Radiology : JACR. 2022.

20. Acute Mesenteric Ischaemia in the Elderly - Results of Combined Endovascular and Surgical Treatment. Primary Study. — Vrba R, Řezáč T, Špička P, et al. Scientific Reports. 2025.

21. Contemporary Management of Acute and Chronic Mesenteric Ischemia: 10-Year Experience From a Multihospital Healthcare System. — Andraska EA, Tran LM, Haga LM, et al. Journal of Vascular Surgery. 2022.